Skip to main content

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Cash Dividends Charged to Retained Earnings This Quarter (QFR120385USNO)

Observation:

Q2 2024: 19,010 (+ more)  Updated: Sep 10, 2024 9:07 AM CDT
Q2 2024:  19,010  
Q1 2024:  12,060  
Q4 2023:  20,185  
Q3 2023:  11,748  
Q2 2023:  17,490  

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

NOTES

Title Release Dates

2017-09-06 2024-09-10
 
Source    

2017-09-06 2024-09-10
 
Release    

2017-09-06 2024-09-10
 
Units    

2017-09-06 2024-09-10
 
Frequency    

2017-09-06 2024-09-10
 
Seasonal Adjustment    

2017-09-06 2024-09-10
 
Notes    

2017-09-06 2024-09-10

RELATED DATA AND CONTENT

Data Suggestions Based On Your Search

Content Suggestions

Related Categories

Releases

Tags


Top